See also this year's filing and all EDGAR filings for this company.
PDF Report 0000922247_2020_Cyclo_Therapeutics_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.016704649522407546, 'aggregate_val': 8551758, 'exp_sum': 8411251, 'exp_to_value': {'CostOfRevenue': 0, 'SellingGeneralAndAdministrativeExpense': 4869160, 'remainder_Expenses': 3542091}} |
Graph
Absolute values for 0000922247, Cyclo Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 3,141,120 |
| 1 | LiabilitiesNoncurrent | 0 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 3,958,069 |
| 4 | PropertyPlantAndEquipmentNet | 13,546 |
| 5 | IntangibleAssets | 0 |
| 6 | AssetsNoncurrent | 51,017 |
| 7 | remainder_Assets | 90,596 |
| 8 | CostOfRevenue | 0 |
| 9 | SellingGeneralAndAdministrativeExpense | 4,869,160 |
| 10 | remainder_Expenses | 3,682,598 |
| 11 | remainder_Revenues | 1,007,198 |
| 12 | remainder_NetIncome | 12,027 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 3,141,120 |
| 1 | Assets | 4,113,228 |
| 2 | Expenses | 8,551,758 |
| 3 | Revenues | 1,007,198 |
| 4 | StockholdersEquity | 972,108 |
| 5 | NetIncome | -7,532,533 |
| 6 | ComprehensiveNetIncome | -7,532,533 |
| 7 | BaseVar | 38,656,972 |
| 8 | EconomicCapitalRatio | -14.8 |
Edgar->Model Mapping
Feature Distribution
Change over Time
